Muscle weakness studies suggest possible therapeutic strategies

20 enero 2015

Potential therapies for central core disease, a condition that can delay development of motor skills such as sitting, crawling and walking in affected infants, have been proposed by researchers. Central core disease is most often caused by a mutation in the gene that makes a protein called ryanodine receptor type 1 (RyR1). RyR1 belongs to a family of proteins that create channels for the controlled release of calcium ions from stores within cells.